Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
42 studies found for:    Open Studies | "Kidney Diseases, Cystic"
Show Display Options
Rank Status Study
1 Recruiting Contrast-enhanced Ultrasound of the Kidney
Conditions: Chronic Kidney Disease;   Cystic Kidney Disease
Intervention: Drug: Perflutren lipid microsphere
2 Recruiting Evaluation of Complex Renal Cyst With CEUS/Functional MRI Versus CT
Conditions: Cystic Renal Diseases;   Kidney Neoplasms
Interventions: Other: Blood/urine sampling;   Other: Conventional routine CT examination;   Other: Contrast-enhanced renal ultrasonography (CEUS);   Other: Functional MRI
3 Recruiting UAB HRFD Core Center: Core A: The Hepato/Renal Fibrocystic Diseases Translational Resource
Conditions: Hepato/Renal Fibrocystic Disease;   Autosomal Recessive Polycystic Kidney Disease;   Joubert Syndrome;   Bardet Biedl Syndrome;   Meckel-Gruber Syndrome;   Congenital Hepatic Fibrosis;   Caroli Syndrome;   Oro-Facial-Digital Syndrome Type I;   Nephronophthisis;   Glomerulocystic Kidney Disease
Intervention:
4 Recruiting Contrast-enhanced Ultrasound for the Evaluation of Complex Renal Cysts
Condition: Complex Renal Cyst
Intervention: Procedure: Contrast-enhanced ultrasound
5 Not yet recruiting Feasibility Study of Metformin Therapy in ADPKD
Condition: Polycystic Kidney, Autosomal Dominant
Interventions: Drug: Metformin;   Drug: Placebo
6 Recruiting Analysis of Clinical and Molecular Genetic Data Influencing the Evolution and Response to Therapy of ADPKD Patients (Autosomal Dominant Polycystic Kidney Disease)
Condition: Autosomal Dominant Polycystic Kidney Disease
Intervention:
7 Not yet recruiting A Study Measuring Quality of Life, Treatment Preference and Satisfaction of ADPKD Patients in Europe
Condition: Autosomal Dominant Polycystic Kidney Disease
Intervention:
8 Recruiting Post-Marketing Surveillance Study of Tolvaptan in Patients With ADPKD
Condition: Polycystic Kidney, Autosomal Dominant
Intervention: Drug: tolvaptan
9 Not yet recruiting CTT on Renogram as an Early Marker of Significant Obstruction in Uretero-pelvic Junction Syndrome
Condition: Ureteropelvic Junction Obstruction
Interventions: Device: ultrasonography;   Device: diuretic renography
10 Recruiting Effect of Water Intake and Water Restriction on Total Kidney Volume in Autosomal Dominant Polycystic Kidney Disease
Condition: ADPKD
Intervention: Other: water
11 Not yet recruiting The Safety and Efficacy of Catheter-based Renal Denervation Using the Vessix™ Renal Denervation System in Autosomal Dominant Polycystic Kidney Disease (ADPKD) Patients With Severe Debilitating Pain
Condition: Autosomal Dominant Polycystic Kidney Disease
Intervention: Device: Vessix
12 Recruiting Pioglitazone and Lumbar Bone Marrow Fat in Chronic Kidney Disease
Condition: Polycystic Kidney Diseases
Intervention: Other: No intervention
13 Not yet recruiting Efficacy of Tolvaptan on ADPKD Patients
Condition: Autosomal Dominant Polycystic Kidney Disease
Intervention: Drug: Tolvaptan
14 Recruiting Indwelling Double-J Ureteral Stent Versus Externalized Modified-Salle Stent for Pyeloplasty
Condition: Ureteropelvic Junction Obstruction
Interventions: Other: internal Double-J stents;   Other: External Stent
15 Recruiting Use of Low Dose Pioglitazone to Treat Autosomal Dominant Polycystic Kidney Disease
Condition: Polycystic Kidney Disease
Interventions: Drug: Pioglitazone;   Drug: Placebo
16 Recruiting Metformin as a Novel Therapy for Autosomal Dominant Polycystic Kidney Disease
Condition: Polycystic Kidney, Autosomal Dominant
Interventions: Drug: Metformin;   Other: Placebo
17 Recruiting Pilot Study of Niacinamide in Polycystic Kidney Disease (NIAC-PKD2)
Condition: Polycystic Kidney Disease
Interventions: Dietary Supplement: Niacinamide;   Other: Placebo
18 Recruiting Effect of the Aquaretic Tolvaptan on Nitric Oxide System
Condition: Autosomal Dominant Polycystic Kidney Disease
Interventions: Drug: Tolvaptan;   Drug: Placebo
19 Recruiting The German ADPKD Tolvaptan Treatment Registry
Condition: ADPKD (Autosomal Dominant Polycystic Kidney Disease)
Intervention:
20 Recruiting Curcumin Therapy to Treat Vascular Dysfunction in Children and Young Adults With ADPKD
Condition: Polycystic Kidney, Autosomal Dominant
Interventions: Drug: Curcumin;   Other: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years